Elevated IL-6 levels are commonly observed in critical illnesses such as sepsis, acute respiratory distress syndrome (ARDS), and COVID-19, leading to interest in therapeutic strategies aimed at IL-6 inhibition. Here, IL6 is linked to acute respiratory distress syndrome.